Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Neurosci Lett ; 825: 137709, 2024 Mar 10.
Article in English | MEDLINE | ID: mdl-38431038

ABSTRACT

Wistar-Kyoto (WKY) rats subjected to chronic mild stress (CMS) represent a valid model of treatment-resistant depression (TRD). Considering that depression is more prevalent in women than in men, in the present study, female rats were used. We investigated the effect of CMS on behavior and different factors involved in neuroinflammatory processes and neuroplasticity in the hippocampus and medial prefrontal cortex (mPFC) of WKY female rats. The results show that unstressed WKY females exhibited hypolocomotion, decreased exploratory behavior, and an increase in the total grooming time. After exposure to CMS, WKY females displayed intensified grooming. To investigate potential neural mechanisms underlying these behavioral changes, we analyzed signaling and inflammatory pathways in the hippocampus and mPFC. The findings indicate reduced BDNF and elevated levels levels of IL-1ß in both brain structures and NLRP3 in the mPFC of unstressed WKY female rats. WKY rats subjected to CMS showed a further decrease in BDNF levels and increased IL-1ß and NLRP3 in these brain structures. WKY showed reduced pERK1/2 and increased pp38 levels in both brain structures, while CMS revealed a further increase of pp38 in WKY in these brain structures. Expressions of p110ß and pAKT were decreased in the hippocampus and mPFC of WKY rats. The CMS further suppressed p110 and the downstream AKT phosphorylation in the hippocampus, but did not affect the p110 and pAKT in the mPFC. Our findings indicate behavioral and molecular differences in genetically vulnerable WKY female rats and in their response to CMS that may be involved in TRD.


Subject(s)
Phosphatidylinositol 3-Kinases , Proto-Oncogene Proteins c-akt , Humans , Male , Rats , Female , Animals , Rats, Inbred WKY , Proto-Oncogene Proteins c-akt/metabolism , Phosphatidylinositol 3-Kinases/metabolism , NLR Family, Pyrin Domain-Containing 3 Protein/metabolism , Brain-Derived Neurotrophic Factor/metabolism , Prefrontal Cortex/metabolism , Hippocampus/metabolism , Depression/metabolism , Stress, Psychological , Disease Models, Animal
2.
Mol Neurobiol ; 61(3): 1495-1506, 2024 Mar.
Article in English | MEDLINE | ID: mdl-37725215

ABSTRACT

Gender differences exist in depression incidence and antidepressant efficacy. In addition to the neurotransmission theory of depression, inflammation and disrupted signaling pathways play crucial roles in the pathophysiology of depression. Endocannabinoids offer a novel approach to treat inflammatory and emotional disorders like depression. URB597, a FAAH inhibitor, reduces endocannabinoids breakdown. In this study, URB597 effects were investigated on the pro-inflammatory cytokine interleukin-1ß (IL-1ß), nucleotide binding and oligomerization domain-like receptor family pyrin domain-containing 3(NLRP3), and mitogen-activated protein kinase (MAPK)/ phosphatidylinositol 3-hydroxy kinase/ protein kinase B (PI3K) signaling in the hippocampus and the medial prefrontal cortex (mPFC) of male and female rats subjected to chronic unpredictable stress (CUS). The results show that CUS induces depression-like behaviors, and the URB597 exhibited antidepressant-like effects inboth sexes. URB597 reduced the CUS-induced NLRP3 and IL-1ß increase in the hippocampus and mPFC of both sexes. URB597 increased the reduced pERK1/2 levels in the mPFC of both sexes and hippocampus of CUS males. URB597 also prevented the increase in p38 phosphorylation after chronic stress in the mPFC of both sexes and in the hippocampus of the females. The CUS suppressed the downstream Akt phosphorylation in the mPFC and hippocampi of both sexes. URB597 produced an up-regulation of the pAkt in the hippocampus of the CUS animals but did not affect the pAkt in the mPFC. These data demonstrated a sexual dimorphism in the neural cell signaling, and in the effects of endocannabinoids, and indicated these dimorphisms are region-specific.


Subject(s)
Benzamides , Carbamates , NLR Family, Pyrin Domain-Containing 3 Protein , Phosphatidylinositol 3-Kinases , Rats , Male , Female , Animals , Rats, Sprague-Dawley , Phosphatidylinositol 3-Kinases/metabolism , Mitogen-Activated Protein Kinases/metabolism , Endocannabinoids , Brain/metabolism , Antidepressive Agents/pharmacology , Signal Transduction , Stress, Psychological/complications , Stress, Psychological/drug therapy
3.
Can J Physiol Pharmacol ; 101(8): 400-412, 2023 Aug 01.
Article in English | MEDLINE | ID: mdl-37201202

ABSTRACT

Endocannabinoids act as a stress response system; simultaneously, the modulation of this system has emerged a novel approach for the therapy of cardiovascular disorders. We investigated the protective effects of the chronic administration of the fatty acid amide hydrolase inhibitor URB597 on morphology, pro-inflammatory and anti-inflammatory cytokine, the cytoplasm-nuclear distribution of JAK2/STAT3, and NF-κB and Nrf2/HO-1 signaling in the left ventricle of female and male rats exposed to chronic unpredictable stress. Our results show that URB597 treatment exhibits an antidepressant-like effect, decreases the heart/body weight ratio, prevents the hypertrophy of cardiomyocytes, and reduces the increased level of IL-6 in the wall of the left ventricle of stressed female and male rats. The phosphorylation levels of JAK2 and STAT3 in the ventricle of male rats treated with URB597 were declined, whereas in female rats the decrease of STAT3 was observed. In addition, URB597 reduced increased NF-κB in both females and males and increased the expression of Nrf2 and HO-1 protein in the cytosol of male rats, whereas did not affect their levels in females. Cardioprotective effects of URB597 could be linked to the ability to inhibit the JAK2 in males and the STAT3 inflammatory signaling pathways in both females and males.


Subject(s)
Cytokines , NF-kappa B , Rats , Male , Female , Animals , NF-kappa B/metabolism , Cytokines/metabolism , NF-E2-Related Factor 2/metabolism , Signal Transduction , STAT3 Transcription Factor/metabolism , Janus Kinase 2/metabolism
4.
Neurosci Lett ; 768: 136363, 2022 01 18.
Article in English | MEDLINE | ID: mdl-34843876

ABSTRACT

An increasing body of evidence shows significant sex differences in the mammalian brain in multiple behaviours and psychiatric and neurological diseases and as well as that the endocannabinoid system may differ between males and females. In this study we investigated sex differences in working, short-term and long-term memory and the expression of ß2-adrenergic and D1- and D2-receptors in the mPFC and hippocampus, brain regions that are involved in stress response and memory modulation in rats exposed to the chronic unpredictable stress (CUS) and the potential beneficial effects of the chronic fatty acid amide hydrolase inhibitor URB597 treatment. Chronically stressed male rats had an improvement of working memory, while stressed females showed very low object-recognition abilities. On the other hand, animals of both sexes exhibited long-term memory impairment. Our results showed that CUS decreased the expression of ß2-adrenoceptors in the mPFC and D1 receptors in the mPFC and hippocampus of male rats and decreased ß2-adrenoceptors and D1- receptors in the hippocampus of female. URB597 treatment had a positive effect on the short-term memory of stressed animals of both sexes whereas failed to restore long-term memory and did not affect the protein levels ß2-adrenoceptors and D1 receptors in the hippocampus of CUS female rats. The present results support that endocannabinoids induced long-term memory and neurochemical alternations which are sex dependent, suggesting sex specific treatment strategies of mental disorders.


Subject(s)
Benzamides/pharmacology , Brain/drug effects , Carbamates/pharmacology , Memory/drug effects , Receptors, Adrenergic, beta/drug effects , Receptors, Dopamine D1/drug effects , Sex Characteristics , Amidohydrolases/antagonists & inhibitors , Animals , Brain/metabolism , Female , Male , Rats , Rats, Wistar , Receptors, Adrenergic, beta/metabolism , Receptors, Dopamine D1/metabolism , Stress, Psychological/complications
5.
Pharmacology ; 107(1-2): 81-89, 2022.
Article in English | MEDLINE | ID: mdl-34794150

ABSTRACT

INTRODUCTION: The present study examined the effects of fatty acid amide hydrolase inhibitor URB597 on the level of plasma catecholamine and their content, synthesis, and degradation in the adrenal medulla of male and female rats subjected to chronic unpredictable stress (CUS). MATERIAL AND METHODS: Male and female Wistar rats were exposed to the 6 weeks of CUS and treated intraperitoneally with either 0.3 mg/kg/day of URB597 or vehicle in the last 2 weeks of stress protocol. Catecholamines' plasma levels and catecholamines' levels in adrenal medulla were examined using Elabscience ELISA kits. Western blot analysis was used to detect the protein in the medulla. RESULTS: The results of our experiment showed that adrenal weights and catecholamine of unstressed control were higher in females and that CUS induced further enlargement of adrenal glands and catecholamine content and its synthesis compared to male rats. CUS caused an increase of plasma norepinephrine and depletion of norepinephrine content as well as unchanged synthesis and degradation of catecholamine in the adrenal medulla of male rats. URB597 reduced enlarged adrenals and catecholamine content and its synthesis in stressed female rats. URB597 reduces increased plasma norepinephrine and restores its content in the adrenal medulla, unchanging the expression of enzyme synthesis, while reduced protein levels of monoamine oxidase A in male rats are exposed to CUS. DISCUSSION: Our results support the role of endocannabinoids as an antistress mechanism that inhibits elevated adrenomedullary activation and promotes its recovery to baseline in both male and female stressed rats.


Subject(s)
Adrenal Medulla/metabolism , Amidohydrolases/antagonists & inhibitors , Benzamides/pharmacology , Carbamates/pharmacology , Catecholamines/metabolism , Pain/metabolism , Stress, Psychological/metabolism , Adrenal Medulla/drug effects , Animals , Benzamides/therapeutic use , Carbamates/therapeutic use , Catechol O-Methyltransferase/metabolism , Endocannabinoids/physiology , Female , Male , Monoamine Oxidase/metabolism , Organ Size/drug effects , Rats, Wistar
6.
Physiol Behav ; 227: 113174, 2020 12 01.
Article in English | MEDLINE | ID: mdl-32966816

ABSTRACT

Sex differences in the susceptibility to chronic unpredictable stress (CUS) and the effects of fatty acid amide hydrolase (FAAH) inhibitor URB597 in rats have been investigated in this study. In this context, we investigated the effects of prolonged treatment with URB597 on behavior, pro-inflammatory interleukin-6 (IL-6) and anti-inflammatory interleukin-10 (IL-10), catecholamine content and the expression of its biosynthetic and degrading enzymes in the hippocampus, hypothalamus and medial prefrontal cortex (mPFC) of rats subjected to CUS. The results show that CUS increases anxiety-like and depression-like behaviors but it was more pronounced in females. The data suggests sex differences in brain cytokines, catecholamines and their enzymes of synthesis and degradation expression in response to CUS. Our findings indicate that the FAAH inhibitor URB597 differently regulated catecholamine levels and its enzymes of synthesis and degradation in the examined brain areas of male and female rats. URB treatment failed to reduce anxiety or restore reduced norepinephrine and did not affect enzymes of catecholamine degradation in the mPFC, hippocampus and hypothalamus of CUS female rats. These studies are important because they investigate the neurochemical consequences of stress related mood disorders that might lead to the development of sex specific treatments.


Subject(s)
Amidohydrolases , Catecholamines , Amidohydrolases/metabolism , Animals , Anxiety , Brain/metabolism , Endocannabinoids , Female , Male , Rats , Stress, Psychological
7.
Int Immunopharmacol ; 85: 106615, 2020 Aug.
Article in English | MEDLINE | ID: mdl-32447219

ABSTRACT

The changes in sympathetic innervations in lymphoid organs could be a key factor in immune dysregulation. The endocannabinoid system has been shown to exhibit potent immunomodulatory effects that may differ between males and females, representing a potential therapeutic target for peripheral and central inflammatory disorders. Thus, in the present study, an examination was made of the effect of fatty acid amide hydrolase inhibitor URB597 treatment on splenic catecholamine content, synthesis, uptake and degradation in chronically unpredictably stressed (CUS) female and male rats. The results show that CUS increases anxiety-like behaviors and that URB597 had an anxiolytic effect on chronically stressed animals of both sexes. CUS induced the expression of plasma interleukin - 6 (IL-6), interleukin - 10 (IL-10) and IL-6 in the spleen, whereas the expression of IL-10 was reduced in the spleen of both sexes. URB597 treatment did not cause changes in IL-6 in plasma or the spleen, whereas it increased IL-10 in the spleen in CUS animals of both sexes. CUS caused a significant depletion of noradrenaline content in the spleen of female rats and a reduction in noradrenaline uptake in the spleen of female rats, while stressed males had a small but insignificant decrease of splenic noradrenaline levels and an enhanced uptake. The FAAH inhibitor URB597 enhances reduced noradrenaline content, affecting its uptake directly at the level of the spleen. It gives rise to the possibility that endocannabinoids exert a neurorestorative effect on the sympathetic nerve system and cell-mediated immune responses in the spleen of chronically stressed rats.


Subject(s)
Amidohydrolases/antagonists & inhibitors , Anti-Anxiety Agents/pharmacology , Benzamides/pharmacology , Carbamates/pharmacology , Catecholamines/metabolism , Spleen/drug effects , Spleen/metabolism , Stress, Physiological/drug effects , Animals , Anti-Anxiety Agents/therapeutic use , Anxiety/drug therapy , Benzamides/therapeutic use , Carbamates/therapeutic use , Catechol O-Methyltransferase/metabolism , Catecholamine Plasma Membrane Transport Proteins/metabolism , Endocannabinoids/pharmacology , Female , Interleukin-10/blood , Interleukin-6/blood , Male , Monoamine Oxidase/metabolism , Neuroprotective Agents/pharmacology , Open Field Test/drug effects , Phenylethanolamine N-Methyltransferase/metabolism , Rats, Wistar , Sex Factors , Spleen/immunology , Stress, Physiological/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...